HSPB6 and osteosarcoma: As indicated by the results of this study, HSPB6 was down-regulated in osteosarcoma, and HSPB6 overexpression was likely to reduce the proliferation, migration, invasion and lung metastasis of osteosarcoma and boost osteosarcoma apoptosis through the ERK signaling pathway.